Cardlytics R&D Spending Growth & History (CDLX)

Cardlytics's r&d spending was $39.8M for fiscal 2025.

View full Cardlytics company overview

Cardlytics annual r&d spending history

Cardlytics annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20252025-12-31$39.8M−$9.8M−19.84%
20242024-12-31$49.6M−$1.7M−3.40%
20232023-12-31$51.4M−$3.1M−5.66%
20222022-12-31$54.4M$16.3M+42.86%
20212021-12-31$38.1M$20.6M+117.34%
20202020-12-31$17.5M$5.8M+49.86%
20192019-12-31$11.7M−$4.5M−27.83%
20182018-12-31$16.2M$4.1M+33.42%
20172017-12-31$12.2M−$1.8M−12.60%
20162016-12-31$13.9M

Cardlytics r&d spending trends

Over the last five fiscal years, Cardlytics's r&d spending increased from $17.5M to $39.8M, a change of $22.2M. The latest reported quarter, Q2 2026, shows $5.5M.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cardlytics source filings ↗

Community posts

It’s quiet here.

No posts about CDLX yet. Start the conversation.

Write the first post